SCHEMBL2657985

SCHEMBL2657985

O=[N+]([O-])c1cccc(CN2CCNCC2)c1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.65
KDM4E B2RXH2 5/20 0.65
TDP1 Q9NUW8 1/20 0.65
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
MAPK1 P28482 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
POLB P06746 2/20 0.61
LMNA P02545 2/20 0.61
MAPT P10636 1/20 0.61
NPSR1 Q6W5P4 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.57
GAA P10253 1/20 0.57
GFER P55789 1/20 0.57
SIGMAR1 Q99720 2/20 0.54
KCNJ1 P48048 1/20 0.54
KCNH2 Q12809 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29531890 1.00 ALDH1A1 (0.65) ALDH1A1KDM4ETDP1MEN1KMT2A
Hydrochloric Acid SCHEMBL2926248 0.99 ALDH1A1 (0.64) ALDH1A1KDM4ETDP1MEN1KMT2A
SCHEMBL15800712 0.89 ALDH1A1 (0.78) ALDH1A1KDM4ETDP1MEN1KMT2A
SCHEMBL922597 0.86 ALDH1A1 (0.70) ALDH1A1KDM4ETDP1MEN1KMT2A
SCHEMBL4572914 0.86 KCNJ1 (0.70) ALDH1A1KDM4ETDP1SIGMAR1KCNJ1
SCHEMBL13398457 0.85 SIGMAR1 (0.54) ALDH1A1KDM4ETDP1MEN1KMT2A
SCHEMBL3568406 0.85 ALDH1A1 (0.68) ALDH1A1KDM4ETDP1MEN1KMT2A
SCHEMBL922442 0.85 ALDH1A1 (0.68) ALDH1A1KDM4ETDP1MEN1KMT2A
SCHEMBL5578769 0.84 ALDH1A1 (0.67) ALDH1A1KDM4ETDP1MEN1KMT2A
SCHEMBL2716970 0.82 ALDH1A1 (0.73) ALDH1A1KDM4ETDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5817489-A BACTERICIDES, OR CHEMICAL INTERMEDIATES THEREOF; DRUG LIBRARIES ISIS PHARMACEUTICALS, INC. (US) 1998-10-06 US claimed
CN-117285485-A Bis-sulfonamide derivative and preparation method and application thereof 复旦大学 2023-12-26 CN disclosed
CN-110615774-B Benzyl piperazine compound with anti-inflammatory activity, preparation method and medical application 安徽中医药大学 2022-11-11 CN disclosed
CN-109111415-B Dendrobium alkaloid derivative, preparation method and medical application 安徽中医药大学 2022-08-23 CN disclosed
CN-114213415-A Macrocyclic pyrimidine derivatives 詹森药业有限公司 2022-03-22 CN disclosed
CN-106164075-B Macrocyclic pyrimidine derivatives 詹森药业有限公司 2021-11-26 CN disclosed
CN-110615774-A Benzyl piperazine compound with anti-inflammatory activity, preparation method and medical application 安徽中医药大学 2019-12-27 CN disclosed
CN-106132964-B Big ring pyridine derivate 詹森药业有限公司 2019-07-19 CN disclosed
CN-109111415-A A kind of dendrobium nobile alcaloid-derivatives, preparation method and medical usage 安徽中医药大学 2019-01-01 CN disclosed
US-10017509-B2 Macrocylic pyrimidine derivatives JANSSEN PHARMACEUTICA NV (BE) 2018-07-10 US disclosed
US-5817489-A BACTERICIDES, OR CHEMICAL INTERMEDIATES THEREOF; DRUG LIBRARIES ISIS PHARMACEUTICALS, INC. (US) 1998-10-06 US disclosed
US-5798360-A ANTIBACTERIAL AGENTS ISIS PHARMACEUTICALS, INC. (US) 1998-08-25 US disclosed
US-5780241-A ALTERING ELECTROCHEMICAL PROPERTIES BY DECYCLIZATION ISIS PHARMACEUTICALS, INC. (US) 1998-07-14 US disclosed
WO-1998020349-A1 COMPLEX CHEMICAL LIBRARIES ISIS PHARMACEUTICALS, INC. (US) 1998-05-14 WO disclosed
US-5731438-A BACTERICIDES; DRUGS ISIS PHARMACEUTICALS, INC. (US) 1998-03-24 US disclosed
WO-1998005332-A1 NOVEL HETEROCYCLE COMPOSITIONS ISIS PHARMACEUTICALS, INC. (US) 1998-02-12 WO disclosed
EP-0252670-B1 2-SUBSTITUTED ALKOXY-3-SUBSTITUTED-PYRAZINES TOYO JOZO KABUSHIKI KAISHA (JP) 1992-01-15 EP disclosed
US-5001237-A 2-substituted alkoxy-3-substituted-pyrazines TOYO JOZO KABUSHIKI KAISHA (JP) 1991-03-19 US disclosed
US-4894453-A ANTICOAGULANTS, CARDIOVASCULAR DISORDERS TOYO JOZO KABUSHIKI KAISHA (JP) 1990-01-16 US disclosed
EP-0252670-A2 2-Substituted alkoxy-3-substituted-pyrazines TOYO JOZO KABUSHIKI KAISHA (JP) 1988-01-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10017509-B2 Macrocylic pyrimidine derivatives EEF2K, VPS26B, VPS28 ALDH1A1 4293/4885KDM4E 1710/4885TDP1 1399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.